(HealthDay)—In an Endocrine Society guideline update, published online in the March issue of the Journal of Clinical Endocrinology & Metabolism, recommendations are presented for the use of romosozumab in the pharmacological management of osteoporosis in postmenopausal women.
Read More
Health Rss 